STOCK TITAN

Intuitive Surgical (ISRG) files Form 144 to sell 336 restricted shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Intuitive Surgical (ISRG) filed a Form 144 reporting a proposed sale of 336 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ with an approximate sale date of 09/03/2025. The filing lists an aggregate market value of $157,956.96 and shows 358,476,506 shares outstanding. The shares to be sold were originally issued as restricted stock: 102 shares acquired 04/27/2023 and 234 shares acquired 04/25/2024; payment is listed as Not Applicable. The filing reports no securities sold during the past three months. Several administrative fields (filer CIK/CCC and issuer contact details) are not populated in the provided text.

Positive

  • Filing documents compliance with Rule 144 and publicly discloses the proposed insider sale
  • Acquisition history for the shares is provided (dates and amounts), improving traceability

Negative

  • None.

Insights

TL;DR: Small insider sale filing; amount is negligible relative to total shares outstanding and is primarily a compliance disclosure.

The Form 144 notifies the market of a proposed sale of 336 restricted shares with an aggregate value of $157,956.96, scheduled via a Morgan Stanley broker on NASDAQ. Given the issuer's outstanding share count of 358,476,506, the position represents an immaterial fraction of equity outstanding. There are no reported sales in the prior three months. From an analytical standpoint, this filing is routine disclosure under Rule 144 and does not, by itself, signal a material change to the company’s capital structure or investor base.

TL;DR: The filing reflects standard insider compliance; documentation of restricted stock origins is appropriate and complete in the tables provided.

The notice records that the shares were acquired as restricted stock from the issuer on two dates and specifies the broker and planned sale date, which aligns with regulatory expectations for transparency about insider dispositions. The absence of reported sales in the prior three months and the clear listing of acquisition dates and amounts support traceability. Some issuer and filer contact fields are blank in the extract, which limits administrative completeness but does not alter the substantive disclosure about the securities to be sold.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ISRG Form 144 report?

The filing reports a proposed sale of 336 common shares via Morgan Stanley Smith Barney LLC on 09/03/2025 on the NASDAQ, with an aggregate market value of $157,956.96.

How were the shares being sold acquired according to the filing?

The shares were acquired as restricted stock from the issuer: 102 shares on 04/27/2023 and 234 shares on 04/25/2024.

Does the Form 144 show any securities sold in the past three months for this account?

The filing states Nothing to Report for securities sold during the past three months.

What is the issuer’s outstanding share count listed in the filing?

The document lists 358,476,506 shares outstanding.

Which broker is named to execute the sale in the Form 144?

The named broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
Intuitive Surgical Inc

NASDAQ:ISRG

View ISRG Stock Overview

ISRG Rankings

ISRG Latest News

ISRG Latest SEC Filings

ISRG Stock Data

167.61B
352.77M
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
SUNNYVALE